Chrysene accelerates the proceeding of chronic obstructive pulmonary disease with the aggravation of inflammation and apoptosis in cigarette smoke exposed mice.
Yuan GaoXinjia ZhouYan ZhouWei ZhangLi ZhaoPublished in: Human & experimental toxicology (2020)
Chrysene, one of the basic polycyclic aromatic hydrocarbons (PAHs), has been reported to make damages to human health and living environment. Chronic obstructive pulmonary disease (COPD) is a progressive disorder with high morbidity and mortality. To investigate the role of chrysene in the development of COPD, male C57BL/6 mice were exposed to the cigarette smoke (CS) followed with the administration of chrysene. Morphological analyses indicated that chrysene caused earlier and severer pathological changes in CS-exposed mice. Besides, CS-exposed mice with chrysene treatment showed obvious collagen deposition, elevated α-smooth muscle actin (α-SMA) expression and reduced E-cadherin abundance at earlier stage, which suggested the acceleration and aggravation of pulmonary fibrosis. Moreover, quantification of leukocytes and pro-inflammatory cytokines in bronchoalveolar lavage fluid (BALF) and lung tissues implied that chrysene significantly exacerbated the proceeding of inflammation in CS-exposed mice. Furthermore, significantly increased apoptotic rates, augmented expressions of apoptotic related proteins and highly expressed TRPV1 were determined in CS-exposed mice with chrysene treatment, which indicated the association between COPD pathogenesis and TRPV1 channel. In summary, our findings elucidate that chrysene accelerates the development of COPD in a murine model with new molecular mechanisms.
Keyphrases
- chronic obstructive pulmonary disease
- high fat diet induced
- polycyclic aromatic hydrocarbons
- lung function
- human health
- oxidative stress
- smooth muscle
- cell death
- multiple sclerosis
- wild type
- type diabetes
- poor prognosis
- insulin resistance
- metabolic syndrome
- air pollution
- spinal cord injury
- adipose tissue
- anti inflammatory
- long non coding rna
- replacement therapy
- signaling pathway
- spinal cord